IT201700009222A1 - COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY - Google Patents

COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY

Info

Publication number
IT201700009222A1
IT201700009222A1 IT102017000009222A IT201700009222A IT201700009222A1 IT 201700009222 A1 IT201700009222 A1 IT 201700009222A1 IT 102017000009222 A IT102017000009222 A IT 102017000009222A IT 201700009222 A IT201700009222 A IT 201700009222A IT 201700009222 A1 IT201700009222 A1 IT 201700009222A1
Authority
IT
Italy
Prior art keywords
colonscopy
virtual
patient
preparation
composition
Prior art date
Application number
IT102017000009222A
Other languages
Italian (it)
Inventor
Stefano Parlati
Original Assignee
Sanitas Lab Chimico Farm S R L In Sigla Sanitas Farm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanitas Lab Chimico Farm S R L In Sigla Sanitas Farm S R L filed Critical Sanitas Lab Chimico Farm S R L In Sigla Sanitas Farm S R L
Priority to IT102017000009222A priority Critical patent/IT201700009222A1/en
Publication of IT201700009222A1 publication Critical patent/IT201700009222A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
IT102017000009222A 2017-01-27 2017-01-27 COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY IT201700009222A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000009222A IT201700009222A1 (en) 2017-01-27 2017-01-27 COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000009222A IT201700009222A1 (en) 2017-01-27 2017-01-27 COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY

Publications (1)

Publication Number Publication Date
IT201700009222A1 true IT201700009222A1 (en) 2018-07-27

Family

ID=59521187

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000009222A IT201700009222A1 (en) 2017-01-27 2017-01-27 COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY

Country Status (1)

Country Link
IT (1) IT201700009222A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
DE102006001199A1 (en) * 2006-01-10 2007-07-12 Medicoforum Gmbh Powder, useful e.g. to prepare drinking solution or finished solution, and in colon hydrotherapy, comprises polyethylene glycol, sodium hydrogen carbonate, sodium chloride and potassium chloride
US20130267607A1 (en) * 2012-04-05 2013-10-10 Gavis Pharmaceuticals, Llc Laxative gel composition
EP2676667A1 (en) * 2005-05-06 2013-12-25 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
EP2676667A1 (en) * 2005-05-06 2013-12-25 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
DE102006001199A1 (en) * 2006-01-10 2007-07-12 Medicoforum Gmbh Powder, useful e.g. to prepare drinking solution or finished solution, and in colon hydrotherapy, comprises polyethylene glycol, sodium hydrogen carbonate, sodium chloride and potassium chloride
US20130267607A1 (en) * 2012-04-05 2013-10-10 Gavis Pharmaceuticals, Llc Laxative gel composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
POMERRI FABIO ET AL: "Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores", EUROPEAN RADIOLOGY, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 27, no. 3, 8 June 2016 (2016-06-08), pages 1044 - 1051, XP036151115, ISSN: 0938-7994, [retrieved on 20160608], DOI: 10.1007/S00330-016-4443-Y *
TRAN KHOI M ET AL: "Miralax: A new standard in bowel preparation for colonoscopy", AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 99, no. 10, Suppl. S, 368, October 2004 (2004-10-01), & 69TH ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-GASTROENTEROLOGY; ORLANDO, FL, USA; OCTOBER 29 -NOVEMBER 03, 2004, pages S119, XP002776099, ISSN: 0002-9270 *

Similar Documents

Publication Publication Date Title
IL255509B (en) Compounds as ccr2 modulators, pharmaceutical compositions comprising same and their use for the treatment of diseases
EP3448874A4 (en) Compositions for the treatment of disease
EP3448875A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
MX2023008693A (en) Modulatory polynucleotides.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
HK1256903A1 (en) Therapeutic compositions for treatment of human immunodeficiency virus
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
HK1248140A1 (en) Extracellular matrix compositions for the treatment of cancer or immunological diseases
HK1259372A1 (en) Therapeutic compounds, compositions and methods of use thereof
IL249640A0 (en) Compositions for the treatment of epistaxis
DK3313370T3 (en) Ophthalmological pharmaceutical composition
SI3302523T1 (en) Composition for the treatment of tissue lesions
EP3145533C0 (en) Compositions for promoting the healing of wounds
GB2546139B (en) Improvements relating to the manufacture of medical devices
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient
WO2015001541A3 (en) Pharmaceutical film composition
HK1258765A1 (en) Therapeutic compounds, compositions and methods of use thereof
IL256919A (en) Pharmaceutical compositions useful for the treatment of tissue injury
WO2015044961A3 (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide
EP3362085C0 (en) Compositions for the treatment of diseases involving mucin
EA201790020A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
IT201700009222A1 (en) COMPOSITION FOR THE PREPARATION OF THE PATIENT FOR VIRTUAL COLONSCOPY
WO2016083315A8 (en) Use of ox1r antagonists for the treatment of inflammatory bowel diseases